Nutromics Receives FDA Breakthrough Device Designation
Melbourne, Australia, September 10, 2026 Nutromics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Melbourne, Australia, September 10, 2026 Nutromics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
Amsterdam, Netherlands, August 7, 2026 Royal Philips has expanded its open patient monitoring ecosystem through a series of strategic...
SINGAPORE, July 14, 2026 The National University Hospital (NUH) has announced plans to significantly expand its use of wearable...
CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
BOSTON, Mass., May 12, 2026 Tolion Health AI has announced the launch of the latest version of its Tolion...
